Global analysis of differentially expressed genes in androgen-independent prostate cancer.
about
LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancerTranscriptional signatures of Ral GTPase are associated with aggressive clinicopathologic characteristics in human cancer.An immunohistochemical study of thioredoxin domain-containing 5 expression in gastric adenocarcinomaThe prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation.Screening key microRNAs for castration-resistant prostate cancer based on miRNA/mRNA functional synergistic network.Identifying gene-disease associations using centrality on a literature mined gene-interaction networkIdentification of transcription factors associated with castration-resistance: is the serum responsive factor a potential therapeutic target?Early side effects and first results of radioligand therapy with (177)Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study.The role of TXNDC5 in castration-resistant prostate cancer-involvement of androgen receptor signaling pathway.ATP-binding cassette transporter A1 (ABCA1) promotes arsenic tolerance in human cells by reducing cellular arsenic accumulation.Therapeutic response and side effects of repeated radioligand therapy with 177Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer.
P2860
Q21202034-C2FBFD36-B04A-4FF5-9D00-9148DD697D2BQ30416201-42C9B0D4-27E5-4111-AC1B-562783D41F62Q35042186-CC20CAFF-53EB-45D2-AEBF-F844E4985870Q36294460-2E59CB5C-3954-4250-8FDB-04283CC2706CQ36685517-C20FA829-EFEC-4B95-A423-A544EB0B9C87Q37283339-E925BDDE-CF42-4379-A65F-6CC8966F75CCQ38318104-8A8B377F-5767-47A3-9420-094F2978EAD7Q38861197-9E103084-2AE0-4CE0-BAF7-7BC82A38D0FAQ38929364-0598116E-E0E3-4834-B4C8-B2BEE99CC81AQ39022539-41497737-EDE5-4BB3-B66B-373DBB503EC4Q40913769-EE84334C-9673-4A9D-AE43-E016C4998612
P2860
Global analysis of differentially expressed genes in androgen-independent prostate cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Global analysis of differentia ...... n-independent prostate cancer.
@en
Global analysis of differentia ...... n-independent prostate cancer.
@nl
type
label
Global analysis of differentia ...... n-independent prostate cancer.
@en
Global analysis of differentia ...... n-independent prostate cancer.
@nl
prefLabel
Global analysis of differentia ...... n-independent prostate cancer.
@en
Global analysis of differentia ...... n-independent prostate cancer.
@nl
P2093
P2860
P356
P1476
Global analysis of differentia ...... n-independent prostate cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.PCAN.4500933
P577
2007-01-02T00:00:00Z